Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy.

@article{Cooperberg2009RiskAA,
  title={Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy.},
  author={Matthew R. Cooperberg and Shiro Hinotsu and Mikio Namiki and Kazuto Ito and Jeanette M Broering and Peter R. Carroll and Hideyuki Akaza},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2009},
  volume={27 26},
  pages={
          4306-13
        }
}
PURPOSE Prostate cancer epidemiology has been marked overall by a downward risk migration over time. However, in some populations, both in the United States and abroad, many men are still diagnosed with high-risk and/or advanced disease. Primary androgen deprivation therapy (PADT) is frequently offered to these patients, and disease risk prediction is not well-established in this context. We compared risk features between large disease registries from the United States and Japan, and aimed to… CONTINUE READING

Figures, Tables, and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 61 CITATIONS

Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen level

  • Journal of Cancer Research and Clinical Oncology
  • 2014
VIEW 8 EXCERPTS
CITES RESULTS, BACKGROUND & METHODS
HIGHLY INFLUENCED

Usefulness of J-CAPRA score for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy.

  • Japanese journal of clinical oncology
  • 2014
VIEW 22 EXCERPTS
CITES BACKGROUND, METHODS & RESULTS
HIGHLY INFLUENCED

Age at diagnosis on prostate cancer survival undergoing androgen deprivation therapy as primary treatment in daily practice: results from Japanese observational cohort

Teruo Inamoto, Haruhito Azuma, +13 authors The Japan Study Group of Prostate Cancer
  • Journal of Cancer Research and Clinical Oncology
  • 2014
VIEW 15 EXCERPTS
CITES BACKGROUND, METHODS & RESULTS
HIGHLY INFLUENCED

The oncological outcome and validation of Japan Cancer of the Prostate Risk Assessment score among men treated with primary androgen-deprivation therapy

  • Journal of Cancer Research and Clinical Oncology
  • 2014
VIEW 16 EXCERPTS
CITES BACKGROUND, METHODS & RESULTS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2010
2018

CITATION STATISTICS

  • 17 Highly Influenced Citations

  • Averaged 6 Citations per year over the last 3 years

  • 11% Increase in citations per year in 2018 over 2017

References

Publications referenced by this paper.
SHOWING 1-10 OF 31 REFERENCES

Cancer statistics, 2008.

  • CA: a cancer journal for clinicians
  • 2008

Current status and prospects of androgen depletion therapy for prostate cancer.

  • Best practice & research. Clinical endocrinology & metabolism
  • 2008

Survival following primary androgen deprivation therapy among men with localized prostate cancer

Pawan Vasudeva, Apul Goel, Divakar Dalela
  • Indian journal of urology : IJU : journal of the Urological Society of India
  • 2008
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…